Cargando…
Fibrinolytic Therapy in Acute Stroke
Acute ischemic stroke is a major cause of morbidity and mortality in Europe, North America, and Asia. Its treatment has completely changed over the past decade with different interventional approaches, such as intravenous trials, intra-arterial trials, combined intravenous/intra-arterial trials, and...
Autores principales: | Millán, Mònica, Dorado, Laura, Dávalos, Antoni |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994114/ https://www.ncbi.nlm.nih.gov/pubmed/21804781 http://dx.doi.org/10.2174/157340310791658758 |
Ejemplares similares
-
Reperfusion Therapies for Acute Ischemic Stroke: An Update
por: Dorado, Laura, et al.
Publicado: (2014) -
Legal medicine implications in fibrinolytic therapy of acute ischemic stroke
por: Sabau, Monica, et al.
Publicado: (2019) -
Assessment of neurologists’ knowledge regarding intravenous fibrinolytic therapy for acute stroke in Shanxi province in China
por: Ma, Liansheng, et al.
Publicado: (2017) -
Evaluation of fibrinolytic medical therapy for patients with acute myocardial infarction
por: Maleki, Ali, et al.
Publicado: (2012) -
Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
por: Asakura, Hidesaku, et al.
Publicado: (2020)